102 related articles for article (PubMed ID: 14961567)
1. Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors.
Ghabreau L; Roux JP; Frappart PO; Mathevet P; Patricot LM; Mokni M; Korbi S; Wang ZQ; Tong WM; Frappart L
Int J Cancer; 2004 Apr; 109(3):317-21. PubMed ID: 14961567
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.
Brustmann H
Pathol Res Pract; 2007; 203(2):65-72. PubMed ID: 17258405
[TBL] [Abstract][Full Text] [Related]
3. Heparanase expression increases throughout the endometrial hyperplasia-cancer sequence.
Canaani J; Ilan N; Back S; Gutman G; Vlodavsky I; Grisaru D
Int J Gynaecol Obstet; 2008 May; 101(2):166-71. PubMed ID: 18221741
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
5. PARP-1 activity in normal and cancerous human endometrium and its relationship with quantity of abasic sites (AP).
Postawski K; Monist M; Keith G
Ginekol Pol; 2011 Jan; 82(1):16-21. PubMed ID: 21469519
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
8. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
9. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
[TBL] [Abstract][Full Text] [Related]
10. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.
Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I
Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121
[TBL] [Abstract][Full Text] [Related]
11. The E-Cadherin expression vs. tumor cell proliferation paradox in endometrial cancer.
González-Rodilla I; Aller L; Llorca J; Muñoz AB; Verna V; Estévez J; Schneider J
Anticancer Res; 2013 Nov; 33(11):5091-5. PubMed ID: 24222154
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the DNA global methylation status and progesterone receptor expression in normal endometrium, endometrioid adenocarcinoma and precursors.
Ghabreau L; Roux JP; Niveleau A; Fontanière B; Mahe C; Mokni M; Frappart L
Virchows Arch; 2004 Aug; 445(2):129-34. PubMed ID: 15221375
[TBL] [Abstract][Full Text] [Related]
13. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
Horn LC; Meinel A; Handzel R; Einenkel J
Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
[TBL] [Abstract][Full Text] [Related]
14. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
[TBL] [Abstract][Full Text] [Related]
15. Contribution of immunohistochemical profile in assessing histological grade of endometrial cancer.
Canlorbe G; Laas E; Bendifallah S; Daraï E; Ballester M
Anticancer Res; 2013 May; 33(5):2191-8. PubMed ID: 23645775
[TBL] [Abstract][Full Text] [Related]
16. Expression of poly-ADP-ribose polymerase (PARP) in endometrial adenocarcinoma: Prognostic potential.
Lawrence LM; Russell R; Denning CE; Zgheib NB; Salisbury T; Lirette ST; Valluri J; Claudio PP; Denning KL
Pathol Res Pract; 2020 Jun; 216(6):152965. PubMed ID: 32360251
[TBL] [Abstract][Full Text] [Related]
17. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasia.
Brustmann H
Int J Gynecol Pathol; 2005 Apr; 24(2):184-92. PubMed ID: 15782075
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]